| ESR | Einstein stoke radius; electric skin resistance; electron spin resonance; equipment service report; ... |
|---|---|
| FUR | 5-fluorouracil and radiation; fluorouracil riboside; fluorouridine; follow-up report; furin membrane... |
| HR | heart rate; hemorrhagic retinopathy; high resolution; higher rate; histamine receptor; hormonal resp... |
| LR | labeled release; laboratory references; laboratory report; labor room; lactated Ringer [solution]; l... |
| MMWR | Morbidity and Mortality Weekly Report |
| diachronic study | A study done over the course of time. For example, a longitudinal study of children with Down syndrome (trisomy 21) might involve the study of 100 children with this condition from birth to 10 years of age. Also called a longitudinal study. The opposite of a synchronic (cross-sectional) study. (12 Dec 1998) |
|---|---|
| double-blind study | A study in which neither the experimenter nor any other assessor of the results, including patients, know which group is subject to which procedure, thus helping assure that the biases or expectations of either will not influence the results. (05 Mar 2000) |
| epidemiologic study characteristics | Types and formulations of studies used in epidemiological and clinical research. (12 Dec 1998) |
| twin study | A method of detecting genetic causes in human traits and genetic factors in behaviour using sets of twins. (12 Dec 1998) |
| foetal doppler study | <radiology> Non-stress test (NST), external monitoring for 20 minutes; poor specificity, greater than4 foetal heart accelerations (greater than15 bpm over baseline for 15 seconds) following foetal movement in foetus greater than34 weeks, no heart accelerations in immaturity, sleep, maternal sedation contraction stress test (CST), external monitoring after oxytocin or maternal breast stimulation, greater than 3 uterine contraction in 10 minutes; 50% specificity uterine and umbilical artery waveform, elevated systolic:diastolic ratio = increased vascular resistance foetal aortic flow volume, 185-246 ml/kg/min see also: biophysical profile, intrauterine growth retardation (IUGR) (12 Dec 1998) |
| follow-up study | Study in which persons exposed to risk or given a designated preventive or therapeutic regimen are observed over a period or at intervals to determine the outcome of the exposure or regimen. (05 Mar 2000) |
| Framingham Heart study | <epidemiology> Ongoing epidemiologic study of a cohort of over 5,000 of the population of Framingham, MA conducted since 1949 under the auspices of the National Institutes of Health and Boston University. (05 Mar 2000) |
| longitudinal study | <epidemiology> A study taking place over time. If individuals are followed, this is a longitudinal cohort study. If individuals are not followed, but classes (usually age classes) are restudied, this is a longitudinal cross-sectional study. The converse of a horizontal study. (05 Dec 1998) |
| acinetobacter infections | Infections with bacteria of the genus acinetobacter. (12 Dec 1998) |
| actinobacillus infections | Infections with bacteria of the genus actinobacillus. (12 Dec 1998) |
| actinomycetales infections | Infections with bacteria of the order actinomycetales. (12 Dec 1998) |
| adenophorea infections | Infections with nematodes of the subclass adenophorea. (12 Dec 1998) |
| adenovirus infections, human | Respiratory and conjunctival infections caused by 33 identified serotypes of human adenoviruses. (12 Dec 1998) |
| aids-related opportunistic infections | Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include pneumocystis carinii pneumonia, kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with mycobacterium avium complex, microsporidium, and cytomegalovirus. (12 Dec 1998) |
| alphavirus infections | Virus diseases caused by members of the alphavirus genus of the family togaviridae. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|